Board of Directors

Jamie Heywood, Chairman
Co-Founder and Chairman, PatientsLikeMe

An MIT-trained mechanical engineer, Jamie entered the field of translational medicine when his 29 year old brother Stephen was diagnosed with ALS, or Lou Gehrig's Disease. Jamie co-founded PatientsLikeMe to ensure patient outcomes become the primary driver of the medical care and discovery process. Jamie is also the founder and past CEO of the ALS Therapy Development Institute (ALS TDI), the world's first non-profit biotechnology company. During his tenure at ALS TDI, Jamie helped pioneer an open research model and industrialized therapeutic validation process that made ALS TDI the world's largest and most comprehensive ALS research program. Jamie has founded or co-founded three other health care companies: AOBiome, Genetic Networks, and Love Steve, and is an active member of a community of innovators working to bring dramatic improvements to the way we discover, develop and deliver effective health. Jamie and his brother were the subject of Pulitzer Prize-winning author Jonathan Weiner's biography His Brother’s Keeper, and the documentary So Much So Fast.

Jun Wang, Director
Founder and CEO of iCarbonX

Dr. Wang co-founded Beijing Genomics Institute (BGI) in 1999, which is now widely recognized as one of world’s premier research facilities committed to excellence in genome sciences. During this time, Dr. Wang managed three rounds of fundraising (about 1B$ in total), and acquired a U.S. public company, Complete Genomics. He was recognized with numerous awards and nominations, such as His Royal Highness Prince Foundation, and “Fortune’s 40 under 40” by Fortune Magazine (2013) and “Highly Cited Researchers 2015” by Thomson Reuters. Dr. Wang founded iCarbonX in 2015. He holds a bachelor’s degree in artificial intelligence and a Ph.D. in bioinformatics from Peking University.